Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-01-25
1997-04-08
Wu, Shean C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546304, 546329, 546340, 546344, 546346, A01N 4340, A61K 3144, C07D21360, C07D21375
Patent
active
056188293
ABSTRACT:
A pharmaceutical composition which comprises a pharmaceutically effective amount of a compound of the formula ##STR1## wherein R.sup.1 represents a hydrogen atom,
R.sup.2 represents --(CH.sub.2).sub.m -A
wherein m is an integer of 0 to 3, and
A represents pyridyl which is unsubstituted or is substituted by C.sub.1 -C.sub.3 alkyl said alkyl being unsubstituted or substituted by phenyl, and R.sup.3, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 each independently represent a hydrogen atom, a halogen atom, C.sub.1 -C.sub.5 alkyl which is unsubstituted or is substituted with a halogen atom or --OR.sup.13 wherein R.sup.13 represents a hydrogen atom or C.sub.1 -C.sub.5 alkyl which is unsubstituted or is substituted with a halogen atom or phenyl, or when their adjacent substituents are taken together, they represent C.sub.1 -C.sub.3 oxyalkylene having one or two oxygen atoms;
or a pharmaceutically acceptable salt thereof, and
a pharmaceutically acceptable carrier therefor.
REFERENCES:
Caplus 1991:101537 (Mongelli et al, EP 388948 Sep. 26, 1990).
Hara Hiroto
Kitano Yasunori
Takayanagi Hisao
Umeki Hiroe
Yano Tamaki
Mitsubishi Chemical Corporation
Wu Shean C.
LandOfFree
Tyrosine kinase inhibitors and benzoylacrylamide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tyrosine kinase inhibitors and benzoylacrylamide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tyrosine kinase inhibitors and benzoylacrylamide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2398023